Mitsias v. I-Flow Corp.

959 N.E.2d 94, 355 Ill. Dec. 66
CourtAppellate Court of Illinois
DecidedSeptember 23, 2011
Docket1-10-1126
StatusPublished
Cited by11 cases

This text of 959 N.E.2d 94 (Mitsias v. I-Flow Corp.) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mitsias v. I-Flow Corp., 959 N.E.2d 94, 355 Ill. Dec. 66 (Ill. Ct. App. 2011).

Opinion

959 N.E.2d 94 (2011)
355 Ill. Dec. 66

Angela MITSIAS, a/k/a Angel Mitsias, Plaintiff-Appellant,
v.
I-FLOW CORPORATION, Stryker Corporation, and Stryker Sales Corporation, Defendants-Appellees (Steven Levin, M.D., Defendant).

No. 1-10-1126.

Appellate Court of Illinois, First District, Fifth Division.

September 23, 2011.

*96 Bruce D. Goodman, Peter M. Dapier, Bradley D. Steinberg, Steinberg, Goodman & Kalish, Chicago, for Appellant.

Paul E. Wojcicki, Matthew C. Jardine, Segal McCambridge Singer & Mahoney, Ltd., Chicago, for I-Flow.

Anthony J. Anscombe, C. Kinnier Lastimosa, Sedgwick, Detert, Moran & Arnold LLP, Chicago, for Stryker Corporation and Stryker Sales Corporation.

OPINION

Justice JOSEPH GORDON delivered the judgment of the court, with opinion.

¶ 1 Plaintiff appeals the dismissal of her products liability suit against I-Flow Corporation, Stryker Corporation, and Stryker Sales Corporation (collectively, the product liability defendants) as time-barred under the two-year limitations period for product liability actions as set forth in section 13-213(d) of the Code of Civil Procedure (735 ILCS 5/13-213(d) (West 2008)).

¶ 2 Dr. Steven Levin performed surgery on plaintiff's left shoulder on October 24, 2001. Subsequently, plaintiff experienced severe pain in her shoulder and was diagnosed with glenohumeral chondrolysis, the destruction of cartilage in the shoulder joint. On October 22, 2003, plaintiff filed an initial medical malpractice suit against Dr. Levin. (Dr. Levin is not a party to the instant appeal.) During the course of discovery in that suit, plaintiff's expert Dr. Anthony Romeo was deposed in two phases, namely, on August 9, 2006, and on October 24, 2007. On August 9, 2006, he testified that the administration of a particular anesthetic agent via a continuous infusion device, also known as a "pain pump," had been showed to be "highly associated" with loss of articular cartilage. *97 On October 24, 2007, at the second phase of his deposition, Dr. Romeo testified that recently published medical literature suggested a link between pain pumps and plaintiff's condition.

¶ 3 Based upon this second deposition, on November 12, 2008, plaintiff voluntarily nonsuited her medical malpractice action. She then refiled her malpractice claims against Dr. Levin on February 11, 2009, adding two product liability counts sounding in strict liability and negligence against the pain pump manufacturers, which are the product liability defendants in the instant appeal.

¶ 4 The product liability defendants filed motions to dismiss plaintiff's product liability claims as untimely. The trial court granted their motions to dismiss. Plaintiff now appeals. For the reasons that follow, we reverse and remand.

¶ 5 I. BACKGROUND

¶ 6 The facts as alleged by plaintiff are as follows. Plaintiff injured her left shoulder while exercising on August 19, 2001. On October 24, 2001, Dr. Levin performed orthopedic surgery on her shoulder at Alexian Brothers Medical Center. As a part of the surgery, Dr. Levin installed a pain pump in plaintiff's left shoulder in order to release Marcaine, a local anesthetic, into the surrounding area during the postoperative recovery period. Following surgery, plaintiff allegedly experienced severe pain in her left shoulder and a significant reduction in its range of motion. As noted, she was eventually diagnosed with glenohumeral chondrolysis, the destruction of "articular cartilage," i.e., joint cartilage, in the shoulder.

¶ 7 On October 22, 2003, plaintiff filed her initial medical malpractice suit against Dr. Levin and Alexian Brothers Medical Center, alleging direct negligence on the part of Dr. Levin and direct negligence and respondeat superior liability on the part of Alexian Brothers Medical Center. Plaintiff did not assert any claims against the product liability defendants in that action.

¶ 8 On August 9, 2006, during the course of discovery, the parties deposed plaintiff's physician, Dr. Romeo. In response to questioning by counsel for Dr. Levin, Dr. Romeo listed three possible ways in which performance of the subject surgery could cause cartilage loss, including the following:

"A third possibility which has become more apparent recently is the use of an interarticular anesthetic agent, particularly a medicine called Marcaine, and so the use of a postoperative interarticular pain pump, which I'm not aware of whether that was done or not, has been shown over the last year-and-a-half to two years to be highly associated with a condition where articular cartilage is aggressively lost in the shoulder after arthroscopic stabilization."

Later in that same deposition, counsel for plaintiff asked Dr. Romeo about the use of Marcaine pain pumps as a potential cause of plaintiff's condition, and Dr. Romeo answered that "in the last year and a half there's been a growing body of evidence that this can cause cartilage death or necrosis and lead to the loss of cartilage in a shoulder."

¶ 9 On October 24, 2007, at the second phase of his deposition, Dr. Romeo testified to a link between the use of pain pumps and glenohumeral chondrolysis:

"Q. In 2007, is it recognized in the literature that the use of Marcaine pain pumps can, in fact, be a cause for loss or destruction of articular cartilage at the glenohumeral joint space?
A. Yes."

*98 Dr. Romeo further testified that the connection between pain pumps and glenohumeral chondrolysis "was not known" in 2001 when Dr. Levin performed surgery on plaintiff and was not discovered until "a few years later."

¶ 10 Plaintiff voluntarily dismissed her initial medical malpractice action on November 12, 2008. Subsequently, on February 11, 2009, plaintiff filed the instant suit, once more seeking damages against Dr. Levin on a medical malpractice theory and adding claims against the product liability defendants on theories of strict liability and negligence.

¶ 11 The product liability defendants filed motions to dismiss plaintiff's complaint as untimely pursuant to the two-year limitations period for product liability actions as stated in section 13-213(d) of the Code of Civil Procedure (735 ILCS 5/13-213(d) (West 2008)). The product liability defendants argued that, at the latest, the statutory limitations period for plaintiff's product liability claims began to run on the day that plaintiff filed her initial action in 2003, because upon the filing of such a claim Illinois law deemed her to be aware of an injury wrongfully caused. In response, plaintiff argued that the limitations period would not begin until October 24, 2007, the date of Dr. Romeo's second deposition session, at which she first became aware of the potential link between the use of a pain pump during her surgery and her injury.

¶ 12 In opposition to the product liability defendants' motion to dismiss, plaintiff filed an affidavit by Dr. Romeo in which he stated:

"It is my understanding, and opinion to a reasonable degree of medical certainty, that any information concerning potential chondrolysis caused by the wrongful use of pain pumps did not occur by publication for which a patient or other lay person might realize that chondrolysis might be wrongfully caused by pain pumps or their design or lack of warnings or instructions until the summer of 2007."

Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Wheeler v. C. R. Bard, Inc.
N.D. Illinois, 2022
Dahms v. Coloplast Corp.
N.D. Illinois, 2020
Lempa v. Sandoz Inc.
N.D. Illinois, 2019
Landreth v. Raymond P. Fabricius, P.C.
2018 IL App (3d) 150760 (Appellate Court of Illinois, 2018)
Cochran v. Smith & Nephew, Inc.
260 F. Supp. 3d 979 (C.D. Illinois, 2017)
Dunning v. Dynegy Midwest Generation, Inc.
2015 IL App (5th) 140168 (Appellate Court of Illinois, 2015)
MJK Partners, LLC v. Husman
877 F. Supp. 2d 596 (N.D. Illinois, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
959 N.E.2d 94, 355 Ill. Dec. 66, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mitsias-v-i-flow-corp-illappct-2011.